Herpes Zoster DNA Vaccines with IL-7 and IL-33 Molecular Adjuvants Elicit Protective T Cell Immunity.

Kim, A Reum; Park, Junsik; Kim, Jong Hoon; Kwak, Jeong-Eun; Cho, Youngran; Lee, Hyojin; Jeong, Moonsup; Park, Su-Hyung; Shin, Eui-Cheol

Kim, A Reum; Park, Junsik; Kim, Jong Hoon; Kwak, Jeong-Eun; Cho, Youngran; Lee, Hyojin; Jeong, Moonsup; Park, Su-Hyung; Shin, Eui-Cheol.

Afiliação

Kim AR; Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea.
Park J; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea.
Kim JH; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea.
Kwak JE; Department of Dermatology and Cutaneous Biology Research Institute, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06230, Korea.
Cho Y; Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea.
Lee H; Research Center, GeneOne Life Science, Inc., Seoul 06060, Korea.
Jeong M; Research Center, GeneOne Life Science, Inc., Seoul 06060, Korea.
Park SH; Research Center, GeneOne Life Science, Inc., Seoul 06060, Korea.
Shin EC; Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea.

Immune Netw ; 18(5): e38, 2018 Oct.

Article em En | MEDLINE | ID: mdl-30402333

Palavras-chave

DNA vaccines; Herpes zoster; IL-33; IL-7; T-cells

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Immune Netw Ano de publicação: 2018 Tipo de documento: Article